Consistent with this, gene and protein expressions of KLF5, a miR‐145 target, were significantly increased in atherosclerosis (Fig. 1B and C, P < 0.05 for both CN and VL patients versus both CR and AR patients for both protein and mRNA expression). This evidence concerns the gene KLF5 and atherosclerosis.